SEC Form 4 · accession 0001493152-26-039246
Akari Therapeutics Plc · AKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kameel D. Farag
Officer — Interim CFO
Period of report
Aug 17, 2026
Accepted (ET)
Aug 19, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001541157
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary SharesF1 | Aug 17, 2026 | A | 1,728 | $7.52 | A | 23,309 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs will vest in full on September 15, 2026.